Sign up to save your podcasts
Or
Share Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 1
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 1
Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas review available efficacy and safety data guiding the optimal integration of oral SERDs into clinical practice.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
6262 ratings
Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas review available efficacy and safety data guiding the optimal integration of oral SERDs into clinical practice.
CME information and select publications here.
More shows like Breast Cancer Update
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
321 Listeners
JAMA Clinical Reviews
495 Listeners
Lung Cancer Update
31 Listeners
Hematologic Oncology Update
76 Listeners
Prostate Cancer Update
14 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
115 Listeners
ASCO Daily News
57 Listeners
Mayo Clinic Talks
290 Listeners
The Curbsiders Internal Medicine Podcast
3,333 Listeners
The ONS Podcast
197 Listeners
The Clinical Problem Solvers
513 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Two Onc Docs
189 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners